Hepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.

David M. Dudzinski: A 59-year-old man with a history of obesity, dyslipidemia, and hypertension was evaluated in the oncology clinic of this hospital because of hepatocellular carcinoma.

The fig summarizes the main treatment strategies for HCC. Hepatocellular carcinoma (HCC) is the most prevalent form of liver ...

Spontaneous rupture and hemorrhage most likely do ... In these cases, the major issue is to distinguish FNH-like nodules from hepatocellular carcinoma (HCC). A mesenchymal hamartoma is another ...

The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.

Given the success of Research Topic <a href=" in Chemotherapy-Resistant Hepatocellular Carcinoma and the rapidly evolving subject area, we are pleased to announce the launch of Volume ...

Findings from the CheckMate 9DW trial support the FDA approval of nivolumab and ipilimumab in unresectable hepatocellular ...

Researchers sought to test the performance of a deep learning model system using longitudinal magnetic resonance imaging (MRI) in predicting early recurrence in patients with hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) is one of the most prevalent ... lack of a tumor capsule, tumor rupture, non-anatomical resection, narrow resection margins (≤2 cm), high alpha-fetoprotein levels ...